News

BioM's articles about and for the Bavarian biotechnology sector


Munich VC Wellington raises €210M fund to back European biotechs

210 Mio € statt der ei­gent­lich er­war­teten 120-150 Mio € waren in­sti­tu­tion­elle In­vestoren, Fam­ily Of­fices und Priv­at­in­vestoren…

TUM and LMU awarded as University of Excellence

The Ex­cel­lence Com­mis­sion con­sist­ing of 39 in­ter­na­tion­al ex­perts and the fed­er­al min­is­ters has se­lec­ted 10 uni­ver­sit­ies…

From an idea to a validated concept

On July 12, the final of the "EIT Health BioEn­tre­pren­eur­ship Lab Ox­ford-Mu­nich 2019" took place at BioMM in Martin­sried near Mu­nich…

European companies selected under EIT Health Go Global Program to reach Japanese and Korean

Fol­low­ing an in­tens­ive se­lec­tion pro­cess through a ded­ic­ated sec­tor-spe­cif­ic jury, el­ev­en European com­pan­ies are laur­eates…

FORUM Science & Health provides new impulses for personalized medicine

On July 3/4, the 2nd FORUM Science & Health took place in Für­sten­feld­bruck near Mu­nich. The suc­cess­ful event brought to­geth­er more…

BioM is partner in the new Peer2scale project

Peer­2s­cale, an HORIZON 2020 pro­ject, is a peer-learn­ing ac­tion between four re­gion­al health agen­cies act­ing as clusters.…

Kress becomes new CEO of MorphoSys

The Su­per­vis­ory Board of MorphoSys AG has today ap­poin­ted Dr. Jean-Paul Kress as its new CEO. The ap­point­ment will take ef­fect on…

TransBioLine: MetaHeps from Martinsried/Munich as partner for new biomarkers

The pro­ject is a five-year pro­gram to gen­er­ate ex­plor­at­ory and con­firm­at­ory data sup­port­ing reg­u­lat­ory qual­i­fic­a­tion and…

bluebird bio's gentherapy ZyntegloTM will be produced by apceth in Munich

ap­ceth Bio­pharma GmbH from Ot­to­brunn/Mu­nich be­comes com­mer­cial man­u­fac­turer in Europe for the gene ther­apy Zyn­te­gloTM. The…

Meet the Bavarian Biotech Cluster at BIO USA in Philadelphia

In der er­sten Juni­woche trifft sich die Szene in Phil­adelphia zur welt­größten Bi­o­tech­no­lo­gie-Part­ner­ing-Kon­fer­enz, der BIO USA.…

Newsletter

Subscribe

Archive



Publish press release

Would you like to enter or update data?
Request login data


Dr. Georg Kääb
Dr. Georg Kääb

Corporate Communications, Managing Director Bavarian Biotech Cluster